Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on February 8, 2025, the Compensation Committee granted ...

Innovative approaches to streamlining biologics production with integrated continuous technologies. Continuous manufacturing ...

The outlook for T-cell malignancies ... with anti-CD3 zeta monoclonal antibody produced bands of predicted size (57.86 kDa) for the CD5CAR-CD3 zeta fusion protein (Figure 1b).

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced ...

Fluorescent fusion antibody chains are co-expressed by IRES-based vectors ... via the cell sorting based on the optimal ψM staining strength from the non-monoclonal cell pool. These clones are ...

Targeting cytotoxic T lymphocytes (CTLs), as chimeric antigen T cells (CAR-T), T cell receptor-engineered ... This approach is based on decorating CTLs with monoclonal antibodies (mAbs) specific to ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

Monoclonal antibodies are novel therapeutic ... their efficacy and between the agents themselves. Antibodies against B cells Rituximab is a depleting antibody directed against CD20 on the surface ...

Bio X Cell has been in the functional antibody supply business for more than 25 years. The company states on its website that it currently offers its products through an international network of ...